Main menu
Edison Group
  • Home
  • Sparks
  • Equities

    Equities

    View All Equities

    Equities by Sector

    Argent Biopharma

    MCap

    AUD5m

    Last close

    AUD0.03

    ▲ 0.01 (21.43%)

    Metals One

    MCap

    —

    Last close

    GBP0.01

    ▲ 0.18 (19.44%)

    BlackRock Latin American Inv Trust

    MCap

    GBP102m

    Last close

    GBP4.58

    ▲ 44.00 (10.63%)

  • Sectors

    Sectors

    View All Sectors
  • Megatrends

    Megatrends

  • Thematics

    Thematics

    View All Thematics

    Latest

  • Audiovisual

    Audiovisual

    View All Audiovisual

    Latest

SynAct Pharma (STO: SYNACT)

Last close As at 05/10/2026

SEK17.12

▲ −0.68 (−3.82%)

Market capitalisation

SEK914m

SynAct Pharma is a clinical-stage biotechnology company focused on the development of treatments to resolve, rather than inhibit, ongoing inflammatory processes in acute and chronic diseases.

Latest News

Latest Insights

View More

Healthcare | Comment

SynAct Pharma (STO:SYNACT) gains WHO dengue validation for resomelagon

Healthcare | podcast

Bull, Bear & Beyond – SynAct Pharma: executive interview

Healthcare | edison tv

SynAct Pharma – executive interview

Healthcare | Flash

SynAct Pharma — Post-hoc analysis strengthens Phase III case

Share Price Chart

Market Data

Share Price SEK17.12
Market Cap SEK914m
52-Week High SEK25.30
52-Week Low SEK7.05
% Change 1M (11.1)
% Change 6M (4.4)
% Change 12M (23.7)
Ave. Daily Volume 1yr 234,160
Visit Website

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Jeppe Øvlesen

    CEO

  • Ann Kristin Led

    CFO